KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Gross Profit (2016 - 2025)

LifeMD (LFMD) has disclosed Gross Profit for 14 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 316.54% year-over-year to $2.8 million, compared with a TTM value of $139.4 million through Dec 2025, up 4.53%, and an annual FY2025 reading of $166.3 million, up 24.71% over the prior year.
  • Gross Profit was $2.8 million for Q4 2025 at LifeMD, down from $51.7 million in the prior quarter.
  • Across five years, Gross Profit topped out at $51.7 million in Q3 2025 and bottomed at -$1.3 million in Q4 2024.
  • Average Gross Profit over 5 years is $29.1 million, with a median of $27.8 million recorded in 2022.
  • The sharpest move saw Gross Profit soared 405.1% in 2021, then tumbled 103.33% in 2024.
  • Year by year, Gross Profit stood at $21.8 million in 2021, then rose by 10.08% to $24.1 million in 2022, then skyrocketed by 64.25% to $39.5 million in 2023, then crashed by 103.33% to -$1.3 million in 2024, then soared by 316.54% to $2.8 million in 2025.
  • Business Quant data shows Gross Profit for LFMD at $2.8 million in Q4 2025, $51.7 million in Q3 2025, and $42.2 million in Q2 2025.